BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34218330)

  • 1. CCL19 enhances CD8
    Yan Y; Zhao W; Liu W; Li Y; Wang X; Xun J; Davgadorj C
    J Gastroenterol; 2021 Aug; 56(8):769-785. PubMed ID: 34218330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL13-mediated recruitment of intrahepatic CXCR5
    Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
    J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
    Zheng M; Sun R; Wei H; Tian Z
    J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.
    Tzeng HT; Tsai HF; Liao HJ; Lin YJ; Chen L; Chen PJ; Hsu PN
    PLoS One; 2012; 7(6):e39179. PubMed ID: 22761734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance.
    Yang S; Wang L; Pan W; Bayer W; Thoens C; Heim K; Dittmer U; Timm J; Wang Q; Yu Q; Luo J; Liu Y; Hofmann M; Thimme R; Zhang X; Chen H; Wang H; Feng X; Yang X; Lu Y; Lu M; Yang D; Liu J
    J Hepatol; 2019 Oct; 71(4):685-698. PubMed ID: 31173811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B Virus.
    Xie X; Luo J; Zhu D; Zhou W; Yang X; Feng X; Lu M; Zheng X; Dittmer U; Yang D; Liu J
    Front Cell Infect Microbiol; 2022; 12():797915. PubMed ID: 35174107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization.
    Furuichi Y; Tokuyama H; Ueha S; Kurachi M; Moriyasu F; Kakimi K
    World J Gastroenterol; 2005 Jun; 11(24):3772-7. PubMed ID: 15968737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte Antigen 6 Complex, Locus C
    Wu LL; Peng WH; Wu HL; Miaw SC; Yeh SH; Yang HC; Liao PH; Lin JS; Chen YR; Hong YT; Wang HY; Chen PJ; Chen DS
    Hepatology; 2019 Jun; 69(6):2364-2380. PubMed ID: 30661248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.
    Kawashima K; Isogawa M; Hamada-Tsutsumi S; Baudi I; Saito S; Nakajima A; Tanaka Y
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.
    Kosinska AD; Pishraft-Sabet L; Wu W; Fang Z; Lenart M; Chen J; Dietze KK; Wang C; Kemper T; Lin Y; Yeh SH; Liu J; Dittmer U; Yuan Z; Roggendorf M; Lu M
    Hepatology; 2017 Jul; 66(1):69-83. PubMed ID: 28295453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
    Catusse J; Leick M; Groch M; Clark DJ; Buchner MV; Zirlik K; Burger M
    Mol Cancer; 2010 Nov; 9():297. PubMed ID: 21092185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection.
    Cao W; Qiu Z; Zhu T; Li Y; Han Y; Li T
    J Clin Virol; 2014 Sep; 61(1):40-6. PubMed ID: 25049205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model.
    Bu Y; Zhao K; Xu Z; Zheng Y; Hua R; Wu C; Zhu C; Xia Y; Cheng X
    Virol Sin; 2023 Jun; 38(3):335-343. PubMed ID: 37141990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL19 and CXCL13 synergistically regulate interaction between B cell acute lymphocytic leukemia CD23+CD5+ B Cells and CD8+ T cells.
    Wang X; Yuling H; Yanping J; Xinti T; Yaofang Y; Feng Y; Ruijin X; Li W; Lang C; Jingyi L; Zhiqing T; Jingping O; Bing X; Li Q; Chang AE; Sun Z; Youxin J; Jinquan T
    J Immunol; 2007 Sep; 179(5):2880-8. PubMed ID: 17709502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate.
    TrehanPati N; Kotillil S; Hissar SS; Shrivastava S; Khanam A; Sukriti S; Mishra SK; Sarin SK
    J Clin Immunol; 2011 Jun; 31(3):509-20. PubMed ID: 21305387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.